Use of Intravitreal Dexamethasone Implant (Ozurdex) Prior to Cataract Surgery in Uveitic Patients
| Autor: | Nur Azem, Raz Gepstein, Shiri Shulman |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Visual acuity business.industry medicine.medical_treatment Perioperative Cataract surgery medicine.disease Surgery 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Ophthalmology 030221 ophthalmology & optometry Medicine Implant medicine.symptom business Uveitis Dexamethasone Chronic uveitis Prophylactic treatment medicine.drug |
| Zdroj: | Journal of Clinical & Experimental Ophthalmology. |
| ISSN: | 2155-9570 |
| DOI: | 10.4172/2155-9570.1000680 |
| Popis: | Purpose: To report the effect of preoperative use of Ozurdex implant, as a prophylactic treatment to cataract surgery in 5 patients with chronic uveitis. Methods: A retrospective case reports. Results: 5 patients with chronic uveitis were included in this study. All patients were treated with Ozurdex prior to cataract surgery. Patients showed significant improvement in visual acuity one month post-surgery and no recurrence of uveitis up to three months post-surgery. Only two patients showed recurrence of CME 3-4 months post Ozurdex injection, which is attributed to Ozurdex maximal effect as was shown in previous studies. Conclusions: Intravitreal Ozurdex may serve as a perioperative anti-inflammatory treatment for uveitic patients undergoing cataract surgery. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|